Sobi - Swedish Orphan Biovitrum

At Sobi, we are bringing brilliant ideas to life. As a global biopharma company we are unlocking the potential of breakthrough innovations, transforming everyday life for people living with rare diseases.​

We are dedicated to capturing the scientific opportunities of our time. With our early roots in Sweden, we started as pioneers in haemophilia. Today we are an innovative leader within rare diseases with a global reach. ​

Sobi has approximately 1,900 employees across Europe, North America, the Middle East, Asia and Australia. In 2024, revenue amounted to SEK 26 billion. Sobi’s share (STO:SOBI) is listed on Nasdaq Stockholm. More about Sobi at sobi.com and LinkedIn.

Please see our Social Media Community Guidelines here: www.sobi.com/en/social-media-policy

© 2025 Swedish Orphan Biovitrum AB (publ) – All rights reserved


3:00

Shared 11 months ago

45 views

3:00

Shared 11 months ago

58 views